Sonova Holding AG has announced that Advanced Bionics (AB) has received Food and Drug Administration (FDA) approval in the United States for its new Naída CI Q70 (Naída CI) sound processor. With this approval, the product is now commercially available in the United States. Earlier this year, the Naída CI processor received regulatory approval for distribution in Europe, Canada, and several other countries in the world.
Naída CI comes with a full performance package in a small size. Significantly improved speech perception, unique ear-to-ear communication, and 100% wireless connectivity to consumer electronics—together with a 40% size reduction compared to AB’s previous BTE processor—are just a few of the processor’s new offerings. For details, visit AdvancedBionics.com.